Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Emend patent?

See the DrugPatentWatch profile for Emend

What “Emend” patent is being referred to?

“Emend” is the brand name for aprepitant (anti-nausea medicine). When people search “Emend patent,” they usually mean one of these:
- the original aprepitant (Emend) drug patent,
- later formulation/patent terms tied to specific products (for example, combination products or dosing forms), or
- generic-entry or exclusivity timing driven by patents and regulatory exclusivities.

To identify the exact patent you mean, you’d typically look for the company/assignee and the country (US/EU/etc.), because patent numbers and expiry dates differ by jurisdiction.

When does the Emend (aprepitant) patent expire?

Patent expiry for Emend/aprepitant depends on the specific patent family and the jurisdiction. A practical way to check the latest, country-specific status (including whether patents are still listed as blocking generic entry) is DrugPatentWatch.com, which tracks patent events and filings across markets: DrugPatentWatch – Emend/aprepitant.

What patents could block generic Emend from entering?

Generic delay can come from:
- primary composition-of-matter patents (for aprepitant itself),
- method-of-use patents (specific approved use claims),
- formulation or delivery-system patents (e.g., particular dosage forms or combinations),
- and sometimes additional filings in later years that extend protection in specific markets.

The exact blockers require matching the specific Emend product and market to the patent list shown in sources like DrugPatentWatch.com: DrugPatentWatch – Emend/aprepitant.

Are there later “Emend” products with different patent timelines?

Yes. Brands that share the “Emend” name can include different dosing forms or combinations, and those can have separate patent families from the original aprepitant compound. That’s why “Emend patent” searches often resolve into “which Emend product” plus “which country.”

DrugPatentWatch can help by listing the specific patents tied to particular market entries: DrugPatentWatch – Emend/aprepitant.

If you want, I can pinpoint the exact patent

Share any one of the following and I’ll narrow it down to the correct patent(s) and likely expiry:
- Country (e.g., US FDA / EMA)
- Patent number or assignee/company
- Whether you mean Emend (aprepitant) or a specific Emend product/strength
- Any link you found during your search



Other Questions About Emend :

emend generic emend 125 mg/80 mg price How many emend doses are needed for chemo? Where can i buy emend? Does emend help with delayed nausea after chemotherapy? Does emend help chemo side effects? Does emend interact with warfarin?